コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 mplex composed of Aph1, Pen2, Nicastrin, and Presenilin 1.
2 pain, potassium channel activity, and binds presenilin 1.
3 familial Alzheimer's disease or mutations in presenilin 1.
4 al domain is important for interactions with presenilin 1.
5 id precursor protein, with or without mutant presenilin 1.
6 the genes for amyloid precursor protein and presenilin-1.
7 64L familial Alzheimer's disease mutation in presenilin-1.
8 rtment that contains APP, beta-secretase and presenilin-1.
9 osomal acidification caused by dysfunctional presenilin-1.
10 endent-interacting protein 1, clusterin, and presenilin-1.
11 0 (ADAM10) and the gamma-secretase component presenilin-1.
12 l components of the gamma-secretase complex, presenilin-1, -2, and nicastrin, accumulate in the mitoc
13 anscription through a Gal4-Tip60 reporter in presenilin-1/2-deficient cells lacking generation of AIC
16 ein (APP), beta-amyloid cleavage enzyme, and presenilin-1, a component of the gamma-secretase complex
17 nd upregulates Notch ligand Delta-1 and also presenilin-1, a protein involved in Notch processing, th
18 -hybrid assay as a bona fide interactor with presenilin-1, a protein which carries mutations that cau
20 ral interneurons in Columbus mutants lacking Presenilin-1 acquire an inappropriate attraction to Netr
21 on, mouse embryonic fibroblasts derived from presenilin 1 and 2 (PS1/2) knockouts recapitulated the g
22 utations in amyloid precursor protein (APP), presenilin 1 and 2 (PSEN1 and PSEN2) cause a subset of e
23 E and BACE2, the gamma-site-cleaving enzymes presenilin 1 and 2, apolipoprotein E, and other Alzheime
24 fically affect the proximity between APP and presenilin 1 and alter presenilin 1 conformation both in
25 nic mice with human familial mutant genes of presenilin 1 and amyloid precursor protein (PS1/APP), th
26 ums of mice expressing human familial mutant presenilin 1 and amyloid precursor protein genes, the le
27 APP-PS1 mice (which coexpress mutated human presenilin 1 and amyloid-beta precursor protein) and 30
28 s mutant human amyloid precursor protein and presenilin 1 and followed the death of individual neuron
30 ditional knock-out mouse studies showed that Presenilin 1 and Notch 1 controlled neural sphere format
31 lly active protein complexes with endogenous presenilin 1 and PEN2 or affect the localization of gamm
35 tions M146V, A246E and deltaE9 and wild-type presenilin 1 and were examined here for gamma-secretase-
36 s in the amyloid precursor protein (APP) and presenilin-1 and -2 genes (PS-1, -2) cause Alzheimer's d
39 rexpressing amyloid precursor protein and/or presenilin-1 and nontransgenic controls were placed into
41 generated by deletion of the genes encoding presenilin-1 and presenilin-2 in bone, is associated wit
42 or protein or the gamma-secretase components presenilin-1 and presenilin-2 that cause familial early-
45 ne of three genes-amyloid precursor protein, presenilin-1 and presenilin-2; however, the molecular ba
46 Tg-AD transgenic mice expressing mutant APP, presenilin-1 and tau have significantly more aggressive
50 able to a decrease in steady-state levels of presenilin 1, and not to altered processing of the amylo
51 essing human amyloid-beta precursor protein, presenilin 1, and tau mutations, and apolipoprotein E, t
53 g the axonal transport of beta-secretase and presenilin-1, and that processing of APP to amyloid-beta
54 f axonal boutons and dendritic spines in APP/Presenilin 1 (APP(swe)/PS1(L166P))-green fluorescent pro
55 icular infusion in amyloid precursor protein/presenilin 1 (APP/PS1) double-transgenic 3-mo-old mice a
56 athology using the amyloid precursor protein/presenilin 1 (APP/PS1) mouse model of AD amyloidosis on
57 LTP impairments in amyloid precursor protein/presenilin 1 (APP/PS1) mutant mice that model Alzheimer'
58 ontaining transgenes for both APP and mutant presenilin 1 (APP/PS1), a similar reduction of pathology
60 )-4 gene in beta-amyloid precursor protein + presenilin-1 (APP+PS1) bigenic mice attenuates AD pathog
63 ressing mutant amyloid precursor protein and presenilin-1 (APP/PS1) were crossed with Ear2(-/-) mice
65 double mutant amyloid precursor protein and presenilin 1 (APPswe/PSEN1dE9) mouse model of Alzheimer'
66 ations in beta-amyloid precursor protein and presenilin 1 are able to induce robust extracellular dep
68 livered bilaterally to the hippocampi of APP+presenilin-1 bigenic mice via an adenoassociated virus s
69 depends on both p120ctn-cadherin and p120ctn-presenilin 1 binding, indicating that p120ctn is the cen
70 gic and cholinergic afferent input, and that presenilin-1, but not tau, may be subject to the same ty
71 otoactivable ATP analog specifically labeled presenilin 1-C-terminal fragments in purified gamma-secr
73 ge on cortical neuron survival by generating presenilin-1 conditional knock-out (PS1 cKO) mice carryi
74 ue of Neuron, report that forebrain-specific Presenilin-1 conditional knockout mice show defects in e
75 imity between APP and presenilin 1 and alter presenilin 1 conformation both in vitro and in vivo, sug
84 ctivity was associated with translocation of presenilin 1 from the perinuclear region to the cell mem
85 RNA and component of gamma-secretase complex presenilin 1 from Tsc1-null cells to wild-type cells lea
87 observations indicate that in the absence of presenilin 1 function, the ability of a cell to move can
89 hat FAD mutations can cause complete loss of Presenilin-1 function in vivo, suggesting that clinical
90 ine whether gamma-secretase modulators alter Presenilin-1/gamma-secretase conformation in intact cell
91 y been shown that AD-linked mutations in the presenilin 1 gene (PS1) enhance inositol triphosphate (I
93 amilial Alzheimer's disease mutations in the presenilin 1 gene (PSEN1) have been previously shown to
96 al is a somatic mosaic for a mutation in the presenilin-1 gene, suggesting a novel molecular mechanis
99 nt from plaques in amyloid precursor protein/presenilin 1-GFP (APPPS1-GFP) nor those in GFP-control m
100 nificantly greater thalamic retention in the presenilin 1 group and significantly greater frontotempo
102 ous studies of the central nervous system in presenilin 1 homozygote mutant embryos identified a prem
104 the mutant phenotypes, and the inclusion of presenilin-1 improves rescue, suggesting that they inter
105 mutant amyloid precursor protein and mutant presenilin 1 in a neuron-specific COX-deficient backgrou
106 of understanding the structural dynamics of presenilin 1 in drug development against Alzheimer's dis
107 in led to marked stabilization of transgenic presenilin 1 in the brains of double-transgenic mice.
108 We now report that expression of the mutant presenilin-1 in these mice induces early and exaggerated
109 D mutations in amyloid precursor protein and presenilin 1 leads to sensitivity to trauma-induced PTSD
110 of beta-amyloid precursor protein (APP) and presenilin-1 leads to a significant inhibition of neurog
111 hroom spines in hippocampal neurons from the presenilin-1 M146V knockin (KI) mouse model of familial
112 -methylcytosine in amyloid precursor protein/presenilin 1 mice along with Alzheimer disease pathology
114 itor dantrolene to amyloid precursor protein-presenilin-1 mice (Thy1-APP(KM670/671NL), Thy1-PS1(L166P
115 ansgenic (Tg) amyloid precursor protein plus presenilin-1 mice when administered at 375 ppm in diet b
116 signaling in Notch1 conditional knockout or Presenilin-1-/- mice results in reduced apoptosis of ear
118 of DSP-8658 in the amyloid precursor protein/presenilin 1 mouse model confirmed an increased microgli
120 el expressing the Swedish mutant APP and the presenilin-1 mutant DeltaE9 reduces amyloid plaque load,
121 uded; 18 were positive for the AD-associated presenilin 1 mutation (carriers, mean age=38) whereas 22
122 Compared to non-carriers, presymptomatic presenilin 1 mutation carriers exhibited thinner cortex
124 yloid load may be detected in presymptomatic presenilin 1 mutation carriers with (11)Carbon-Pittsburg
127 zheimer's disease caused by the E280A single presenilin-1 mutation, thirty carriers of the mutation w
128 m persons who have or will develop AD due to Presenilin 1 mutations or Trisomy 21, but not in skin fi
130 state examination >/= 20) carriers of seven presenilin 1 mutations, comparing them with groups of co
132 onverting enzyme, amyloid precursor protein, presenilin 1, neprylisin or insulin-degrading enzyme.
135 Abeta42) by around 70%, whereas knockdown of presenilin 1, one of the essential gamma-secretase compl
136 In Alzheimer's disease, mutations in APP or presenilin 1 or 2 cause autosomal dominant disease and t
137 Alzheimer's disease-associated mutations in presenilin 1 or 2 or amyloid precursor protein result in
138 milial Alzheimer disease (FAD) patients with presenilin-1 or -2 mutations exhibit altered processing
139 protein components (Aph-1, Pen-2, nicastrin, presenilin-1, or presenilin-2) of the gamma-secretase in
140 logue of the human gamma-secretase component presenilin 1, partially rescues the lethality associated
142 l AD (FAD), are associated with mutations in presenilin 1, presenilin 2, or the amyloid precursor pro
143 's disease, encompassing 25 mutations in the presenilin-1 (PS-1) gene, compared to sporadic Alzheimer
146 Alzheimer's disease-linked mutations in presenilin-1 (PS-1) reportedly impair ER stress-mediated
148 tides, beta-site APP-cleaving enzyme (BACE), presenilin-1 (PS-1), caspase-3, and caspase-mediated cle
149 P cleaving enzymes beta-secretase [BACE] and presenilin-1 [PS-1], and putative clearance molecules, l
154 how that amyloid precursor protein (APP) and presenilin 1 (PS1) double-transgenic (APP/PS1) mice demo
155 emory in amyloid precursor protein (APP) and presenilin 1 (PS1) double-transgenic mice, a well establ
158 terminal fragment (betaCTF), and then by the Presenilin 1 (PS1) enzyme in the gamma-secretase complex
159 ent induced a decrease in the association of presenilin 1 (PS1) fragments with lipid rafts where cata
161 ces required for the expression of the human presenilin 1 (PS1) gene have been identified between -11
167 precursor (APP) and the APP-cleaving enzyme presenilin 1 (PS1) have enabled much progress in underst
168 s demonstrated previously, overexpression of presenilin 1 (PS1) holoprotein does not change the level
169 ic ablation studies have revealed a role for presenilin 1 (PS1) in embryonic neurogenesis, little inf
171 In our previous study we demonstrated that presenilin 1 (PS1) interacts with cytoplasmic linker pro
185 crossed bitransgenic mice expressing APP and presenilin 1 (PS1) mutations with mice overexpressing RT
186 ne (S) and threonine (T) residues within the Presenilin 1 (PS1) N-terminus and in the large hydrophil
187 large membrane protein complexes containing presenilin 1 (PS1) or presenilin 2 (PS2), aph-1a or aph-
188 f four requisite integral membrane proteins: presenilin 1 (PS1) or presenilin 2 (PS2), nicastrin, Pen
190 MRK-560 displays a strong preference for the presenilin 1 (PS1) over PS2 subclass of gamma-secretases
196 ion (GD) conditions, decreased expression of presenilin 1 (PS1) results in decreased neuronal surviva
199 Using the amyloid precursor protein (APP)/presenilin 1 (PS1) transgenic mouse model, we found that
200 ssue of Neuron report that the expression of Presenilin 1 (PS1) variants, responsible for the early o
201 ransmembrane domains (TMDs) 4 and 5 of human presenilin 1 (PS1), a catalytic subunit of gamma-secreta
202 g is regulated by multiple factors including presenilin 1 (PS1), a major component of the gamma-secre
204 The gamma-secretase complex, comprising presenilin 1 (PS1), PEN-2, APH-1 and nicastrin, is a mem
206 To differentiate multiple activities of presenilin 1 (PS1), we generated transgenic mice express
207 gamma-Secretase, or its catalytic subunit presenilin 1 (PS1), were upregulated by exposure to eith
208 nents of the gamma-secretase complex, namely presenilin 1 (PS1)-derived fragments, mature nicastrin,
210 f mutant presenilin 1 genes (PSEN1) encoding presenilin 1 (PS1)variants causes autosomal dominant for
211 u(P301L)), and physiological levels of M146V-presenilin-1 (PS1(M146V)) display extracellular amyloid-
212 approach to replace the endogenous wild-type presenilin-1 (PS1) allele with the PS1(M146V) allele in
217 us work in non-neuronal cells indicates that presenilin-1 (PS1) associates with cytoskeletal elements
218 gamma-secretase was carried out by crossing presenilin-1 (PS1) floxed mice with CD4-Cre mice and PS2
219 Co-expression of C99 with mutant forms of presenilin-1 (PS1) found in familial Alzheimer's disease
220 igate the impact of the c.548G>T mutation on presenilin-1 (PS1) function in vivo, we introduced this
228 es generated by cyclooxygenase-2 (COX-2) and presenilin-1 (PS1) mediate pro-inflammatory signaling an
229 red that, in amyloid precursor protein (APP)/presenilin-1 (PS1) mice (age 3-4 mo), a prominent mouse
230 ut mice with amyloid precursor protein (APP)/presenilin-1 (PS1) mice overexpressing mutant APP and PS
231 (n = 5) and symptomatic (n = 5) carriers of presenilin-1 (PS1) mutations (C410Y or A426P) that lead
234 amyloid-beta precursor protein (AbetaPP) and presenilin-1 (PS1) recapitulate several aspects of this
236 g APP transgenes in Drosophila and mice with presenilin-1 (PS1) transgenes harboring mutations that c
238 tase requires an endoproteolytic cleavage in presenilin-1 (PS1) within a peptide loop encoded by exon
242 trin (NCT) in the extracellular (EC) domain, presenilin-1 (PS1), anterior pharynx defective 1, and pr
243 Other gamma-secretase components include presenilin-1 (PS1), APH-1, and PEN-2, all of which span
246 irst identified through its interaction with Presenilin-1 (PS1), the molecule most frequently mutated
247 e Cri-du-Chat and it directly interacts with presenilin-1 (PS1), the protein most frequently mutated
250 ron emission tomography (PET) imaging in the presenilin-1 (PS1)/amyloid precursor protein (APP) trans
251 ies at the interface between two subunits of presenilin-1 (PS1); however, evidence suggests the exist
252 ecifically labels the N-terminal fragment of presenilin-1 (PS1-NTF) in cell membranes as well as in l
253 ial AD (FAD; amyloid precursor protein [APP]/presenilin 1 [PS1]) ameliorated the autophagocytic defec
254 human amyloid precursor protein (APPsw) and presenilin 1 (PS1DeltaE9) genes, each independent causes
255 xpressing autosomal-dominant human AD genes, presenilin-1 (PS1DeltaE9) and amyloid precursor protein
256 mutant amyloid precursor protein (APPsw) and presenilin-1 (PS1DeltaE9) was characterized for histolog
257 ippocampal neurons derived from mice lacking presenilin 1 (Psen1(-/-) mice) or expressing a familial
258 in amyloid precursor protein (APP(Swe)) and presenilin 1 (PSEN1(M146V)) and derived cortical neurons
260 -related accumulation of Abeta deposition in presenilin 1 (PSEN1) E280A mutation carriers across the
261 een January and August, 2010, 18-26-year-old presenilin 1 (PSEN1) E280A mutation carriers and non-car
266 ations in amyloid precursor protein (APP) or presenilin 1 (PSEN1), sporadic Alzheimer's disease (n =
267 eferred to as ABCC1), we measured N1(IC) and presenilin 1 (PSEN1), the catalytic subunit of gamma-sec
268 biomarkers are characterized and compared in presenilin 1 (PSEN1)E280A mutation carriers and noncarri
269 t, it resulted in a significant reduction of presenilin 1 (PSEN1, alias PS1), nicastrin (NCSTN) , pre
272 ve identified 2 new sequence variants in the presenilin-1 (PSEN1) gene promoter leading to reduced ge
273 nine insertion at codon 352 (insR352) in the presenilin-1 (PSEN1) gene was identified in the proband,
274 l dominant, highly penetrant mutation in the presenilin-1 (PSEN1) gene, and performed genome-wide ass
277 munoblotting, and a fluorogenic enzyme assay presenilin-1 (required for gamma-secretase activity) and
278 is of five different AD-causing mutations in presenilin-1 revealed that all result in drastic reducti
279 mutated human amyloid precursor protein and presenilin 1 show dramatic parallels to AD, although non
281 mational changes in transmembrane domains of presenilin 1 that affect the proteolytic activity of the
282 ne substitutions in the prion protein and in presenilin 1 that underlie the development of a prion di
283 essing mutated amyloid precursor protein and presenilin-1 that develop massive cerebral Abeta loads.
285 on of Abeta(42/43) by familial AD mutants of presenilin 1, the catalytic subunit of gamma-secretase,
286 ent chaperone, cyclophilin B, from assisting presenilin 1 to fold properly, leading to its aggregatio
288 tration of bifunctionalized liposomes to APP/presenilin 1 transgenic mice (aged 10 months) for 3 week
290 Following Abeta-VLP immunizations of APP/presenilin 1 transgenic mice, a model for human AD, we o
291 isease-causing amyloid precursor protein and presenilin 1 variants, we found that coexpression of wil
292 tution at codon 206 (Gly206Ala) in exon 7 of presenilin 1 was observed in 23 individuals from 8 (42%)
293 Choosing from over 130 FAD mutations in Presenilin-1, we introduced 14 corresponding mutations a
294 reduced quantities of the processed, active presenilin 1 were observed in brains of cyclophilin B kn
295 l domain of PEN-2 prevented association with presenilin 1, whereas glycosylation in the C-terminal re
296 ate gene because beta catenin interacts with presenilin 1, which has many mutations that elevate Abet
297 iophysical and genetic studies indicate that presenilin-1, which contains the proteolytic active site
298 g proteins, and prevented the association of presenilin 1 with N-cadherin and VE-cadherin, thereby co
299 rexpression of amyloid precursor protein and presenilin 1 with Swedish and L166P mutations, respectiv
300 man, including human-specific correlation of presenilin-1 with oligodendrocyte markers, and significa
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。